Browsing Tag
Joe Bolen
2 posts
Lilly (NYSE: LLY) to acquire Orna Therapeutics for $2.4bn to expand in vivo CAR-T strategy
Eli Lilly and Company (LLY) to acquire Orna Therapeutics for up to $2.4B. Explore how in vivo CAR-T and circular RNA may transform autoimmune therapy.
February 12, 2026
PureTech Health acquires LYT-100 for lymphedema treatment
US biopharma company PureTech Health has acquired a clinical-stage product candidate called LYT-100, which will be developed as…
July 18, 2019